148 related articles for article (PubMed ID: 37325926)
21. Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice.
van Beek DJ; Pieterman CRC; Wessels FJ; van de Ven AC; de Herder WW; Dekkers OM; Zandee WT; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
Front Endocrinol (Lausanne); 2022; 13():926491. PubMed ID: 36277719
[TBL] [Abstract][Full Text] [Related]
22. Early-Onset/Young-Onset Colorectal Carcinoma: A Comparative Analysis of Morphological Features and Biomarker Profile.
Hashmi AA; Aslam M; Rashid K; Ali AH; Dowlah TU; Malik UA; Zia S; Sham S; Zia F; Irfan M
Cureus; 2023 Jul; 15(7):e42340. PubMed ID: 37621838
[TBL] [Abstract][Full Text] [Related]
23. Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms.
Andreasi V; Muffatti F; Guarneri G; Falconi M; Partelli S
Curr Treat Options Oncol; 2020 Apr; 21(6):48. PubMed ID: 32350693
[TBL] [Abstract][Full Text] [Related]
24. Differences in Age at Onset of Symptoms, and Effects of Genetic Variants, in Patients With Early vs Late-Onset Idiopathic Chronic Pancreatitis in a North American Cohort.
Lewis MD; Talluri J; Wilcox CM; Abberbock JN; Tang G; Conwell DL; Banks PA; Cote GA; Sherman S; Alkaade S; Gardner TB; Anderson MA; Sandhu BS; Muniraj T; Forsmark CE; Guda N; Gelrud A; Romagnuolo J; Brand R; LaRusch J; Amann ST; Slivka A; Whitcomb DC; Yadav D
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):349-357. PubMed ID: 32240833
[TBL] [Abstract][Full Text] [Related]
25. Does Prior Cancer Have an Influence on the Survival Outcomes of Patients with Localized Pancreatic Neuroendocrine Tumors?
Wang L; Li G; Bing YT; Tian ML; Wang HY; Yuan CH; Xiu DR
Chin Med Sci J; 2021 Dec; 36(4):284-294. PubMed ID: 34986965
[TBL] [Abstract][Full Text] [Related]
26. C1QA and COMP: plasma-based biomarkers for early diagnosis of pancreatic neuroendocrine tumors.
Gorai PK; Bharti PS; Kumar S; Rajacharya GH; Bandyopadhyay S; Pal S; Dhingra R; Kumar R; Nikolajeff F; Kumar S; Rani N
Sci Rep; 2023 Nov; 13(1):21021. PubMed ID: 38030709
[TBL] [Abstract][Full Text] [Related]
27. Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
Krauss T; Ferrara AM; Links TP; Wellner U; Bancos I; Kvachenyuk A; Villar Gómez de Las Heras K; Yukina MY; Petrov R; Bullivant G; von Duecker L; Jadhav S; Ploeckinger U; Welin S; Schalin-Jäntti C; Gimm O; Pfeifer M; Ngeow J; Hasse-Lazar K; Sansó G; Qi X; Ugurlu MU; Diaz RE; Wohllk N; Peczkowska M; Aberle J; Lourenço DM; Pereira MAA; Fragoso MCBV; Hoff AO; Almeida MQ; Violante AHD; Quidute ARP; Zhang Z; Recasens M; Díaz LR; Kunavisarut T; Wannachalee T; Sirinvaravong S; Jonasch E; Grozinsky-Glasberg S; Fraenkel M; Beltsevich D; Egorov VI; Bausch D; Schott M; Tiling N; Pennelli G; Zschiedrich S; Därr R; Ruf J; Denecke T; Link KH; Zovato S; von Dobschuetz E; Yaremchuk S; Amthauer H; Makay Ö; Patocs A; Walz MK; Huber TB; Seufert J; Hellman P; Kim RH; Kuchinskaya E; Schiavi F; Malinoc A; Reisch N; Jarzab B; Barontini M; Januszewicz A; Shah N; Young WF; Opocher G; Eng C; Neumann HPH; Bausch B
Endocr Relat Cancer; 2018 Sep; 25(9):783-793. PubMed ID: 29748190
[TBL] [Abstract][Full Text] [Related]
28. Comparison of clinical outcomes between enucleation and regular pancreatectomy in patients with non-functional pancreatic neuroendocrine tumors: a retrospective multicenter and propensity score-matched study.
Yang Z; Gao H; Lu J; Niu Z; Zhu H; Zong Y; Song X; Yang F; Zhou X
Jpn J Clin Oncol; 2021 Apr; 51(4):595-603. PubMed ID: 33395471
[TBL] [Abstract][Full Text] [Related]
29. The dilemma of "indeterminate" interpretations of pancreatic neuroendocrine tumors on fine needle aspiration.
Ahmed A; VandenBussche CJ; Ali SZ; Olson MT
Diagn Cytopathol; 2016 Jan; 44(1):10-3. PubMed ID: 26402138
[TBL] [Abstract][Full Text] [Related]
30. Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients.
Speisky D; Duces A; Bièche I; Rebours V; Hammel P; Sauvanet A; Richard S; Bedossa P; Vidaud M; Murat A; Niccoli P; Scoazec JY; Ruszniewski P; Couvelard A;
Clin Cancer Res; 2012 May; 18(10):2838-49. PubMed ID: 22461457
[TBL] [Abstract][Full Text] [Related]
31. EUS-guided FNA cytology of pancreatic neuroendocrine tumour (PanNET): a retrospective study of 132 cases over an 18-year period in a single institution.
Chen S; Lin J; Wang X; Wu HH; Cramer H
Cytopathology; 2014 Dec; 25(6):396-403. PubMed ID: 24635775
[TBL] [Abstract][Full Text] [Related]
32. Pre- and intraoperative diagnostic requirements, benefits and risks of minimally invasive and robotic surgery for neuroendocrine tumors of the pancreas.
Gharios J; Hain E; Dohan A; Prat F; Terris B; Bertherat J; Coriat R; Dousset B; Gaujoux S
Best Pract Res Clin Endocrinol Metab; 2019 Oct; 33(5):101294. PubMed ID: 31351817
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy of conversion therapy and direct surgical resection in patients with metastatic pancreatic neuroendocrine tumors].
Gao HL; Dong J; Xu J; Yu XJ
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1007-1013. PubMed ID: 35399020
[No Abstract] [Full Text] [Related]
34. Significance of Lymph Node Metastasis in Resectable Well-differentiated Pancreatic Neuroendocrine Tumor.
Harimoto N; Hoshino K; Muranushi R; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Suzuki H; Arakawa K; Hirai K; Fukazawa T; Ikota H; Shirabe K
Pancreas; 2019 Aug; 48(7):943-947. PubMed ID: 31268980
[TBL] [Abstract][Full Text] [Related]
35. High-Grade Progression Confers Poor Survival in Pancreatic Neuroendocrine Tumors.
Botling J; Lamarca A; Bajic D; Norlén O; Lönngren V; Kjaer J; Eriksson B; Welin S; Hellman P; Rindi G; Skogseid B; Crona J
Neuroendocrinology; 2020; 110(11-12):891-898. PubMed ID: 31658459
[TBL] [Abstract][Full Text] [Related]
36. Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
Luchini C; Lawlor RT; Bersani S; Vicentini C; Paolino G; Mattiolo P; Pea A; Cingarlini S; Milella M; Scarpa A
Curr Oncol Rep; 2021 Jul; 23(9):106. PubMed ID: 34269919
[TBL] [Abstract][Full Text] [Related]
37. Outcomes after primary tumor resection of metastatic pancreatic neuroendocrine tumors: An analysis of the National Cancer Database.
Kaslow SR; Hani L; Cohen SM; Wolfgang CL; Sacks GD; Berman RS; Lee AY; Correa-Gallego C
J Surg Oncol; 2023 Aug; 128(2):262-270. PubMed ID: 37042430
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for short recurrence-free survival after resection of pancreatic neuroendocrine tumor (PanNET) liver metastases: which patients should undergo resection?
Masui T; Nagai K; Anazawa T; Kasai Y; Sato A; Nakano K; Uchida Y; Yogo A; Kawaguchi Y; Takaori K; Uemoto S
Scand J Gastroenterol; 2020 Apr; 55(4):479-484. PubMed ID: 32223573
[No Abstract] [Full Text] [Related]
39. Prognostic significance of neutrophil-lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages.
Harimoto N; Hoshino K; Muranushi R; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Suzuki H; Arakawa K; Hirai K; Fukazawa T; Ikota H; Shirabe K
Pancreatology; 2019 Sep; 19(6):897-902. PubMed ID: 31409525
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotypic and molecular characterization of pancreatic neuroendocrine tumors producing serotonin.
Depoilly T; Leroux R; Andrade D; Nicolle R; Dioguardi Burgio M; Marinoni I; Dokmak S; Ruszniewski P; Hentic O; Paradis V; De Mestier L; Perren A; Couvelard A; Cros J
Mod Pathol; 2022 Nov; 35(11):1713-1722. PubMed ID: 35739266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
